Biotech Digest – XENT Gets FDA Approval, AGN Announces Acquisition, IONS Licenses Product
December 12, 2017 at 10:26 AM EST
Intersect ENT Inc. reported the FDA approval for its SINUVA implant, designed to be used for treating recurrent nasal polyps in patients who have had previous ethmoid sinus surgery.
